✦ LIBER ✦

Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study

✍ Scribed by Marianne J Rutten; Katja N Gaarenstroom; Toon Van Gorp; Hannah S van Meurs; Henriette JG Arts; Patrick M Bossuyt; Henk G Ter Brugge; Ralph HM Hermans; Brent C Opmeer; Johanna MA Pijnenborg; Henk WR Schreuder; Eltjo MJ Schutter; Anje M Spijkerboer; Celesta WM Wensveen; Petra Zusterzeel; Ben Willem J Mol; Gemma G Kenter; Marrije R Buist

Book ID: 115010427
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 175 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-31

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of laparoscopy to assess the chance

Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study

✍ Anna Fagotti; Francesco Fanfani; Manuela Ludovisi; Roberto Lo Voi; Giuseppe Bifu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Hyperthermic intraperitoneal chemotherap

Hyperthermic intraperitoneal chemotherapy following extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: Result of a prospective phase II study

✍ Lim, M.; Im, M.; Yoo, H.; Seo, S.; Kang, S.; Park, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Survival impact of multiple bowel resect

Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: A case–control study

✍ Ritu Salani; Marianna L. Zahurak; Antonio Santillan; Robert L. Giuntoli II; Robe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 206 KB

A prospective trial evaluating the abili

A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

✍ Suidan, R.S.; Ramirez, P.T.; Sarasohn, D.; Teitcher, J.; Mironov, S.; Iyer, R.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase III randomized trial of BAY 12-9

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study

✍ H. Hirte; I.B. Vergote; J.R. Jeffrey; R.N. Grimshaw; S. Coppieters; B. Schwartz; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

5002 ORAL Results from a Phase II random

5002 ORAL Results from a Phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer

✍ Makhija, S.; Glenn, D.; Ueland, F.; Dizon, D.; Paton, V.; Lin, C.Y.; Amler, L.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB